12:00 AM
 | 
Jan 21, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Atossa Genetics sales and marketing update

Atossa launched its ForeCYTE Breast Health Test in the U.S. to differentiate between normal, premalignant and malignant tumor cells...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >